{
  "id": 6580496,
  "title": "BridgeBio Oncology slides as it tightens the scope of its KRAS program",
  "url": "https://urgent.news/2026/09/10/bridgebio-oncology-slides-as-it-tightens-the-scope-of-its-kras-program",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-10T11:09:03.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/bridgebio-oncology-slides-as-it-tightens-the-scope-of-its-kras-program/"
  },
  "original_language": "en",
  "account": null,
  "summary": "BridgeBio Oncology Therapeutics' share price {$BBOT} plummeted by about 24% at market close Wednesday on the back of plans that it is scaling back its pipeline to focus on developing its lead KRAS inhibitor for ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}